Delaware
|
001-37568
|
26-4231384
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
300 Connell Drive, Suite 4000
Berkeley Heights, NJ
|
07922
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code
|
(800) 208-3343
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
|
PDS Biotechnology Corporation
|
||||
Dated: March 27, 2019
|
||||
By:
|
/s/ Frank Bedu-Addo
|
|||
Name:
|
Frank Bedu-Addo
|
|||
Title:
|
Chief Executive Officer
|